Global Pain Management Devices Market Outlook, Competitive Insights, and Forecast - 2030



“The pain management devices market was valued at USD 4.86 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.90% between 2024 and 2030, reaching approximately USD 7.67 billion by 2030.”


Pain management devices are designed to alleviate chronic and acute pain in patients suffering from conditions like arthritis, cancer, musculoskeletal disorders, and post-operative pain. These devices offer a drug-free approach to pain relief and have gained significant traction due to the rising demand for safer alternatives to opioids, which have historically dominated pain management but are associated with high addiction and adverse effects.

Pain Management Devices Market Insights  

The pain management devices market has seen substantial growth in recent years due to the increasing prevalence of chronic pain conditions, rising geriatric populations, and growing awareness of alternative pain management options. Non-invasive devices, such as transcutaneous electrical nerve stimulators (TENS), radiofrequency ablation (RFA) devices, and spinal cord stimulators (SCS), are among the leading product segments. Technological advancements have also driven market growth, with innovations such as wearable pain relief devices, wireless pain management systems, and remote patient monitoring, which offer improved patient outcomes.


In addition, an increasing number of patients are opting for minimally invasive treatments due to shorter recovery times, reduced side effects, and improved quality of life, further bolstering the market.

Key Pain Management Devices Companies In The Market Landscape:

The key Pain Management Devices companies in the market include - Smiths Medical, B. Braun Melsungen AG, Baxter, Boston Scientific Corp., Colfax Corp., Medtronic Plc, Nevro Corp., Abbott, Stryker, Omron Healthcare, Inc., Stimwave LLC, and others.


Pain Management Devices Competitive Landscape  

The pain management devices market is highly competitive, with numerous players vying for market share. Key players in the market include Medtronic, Boston Scientific, Abbott Laboratories, and Nevro Corp. These companies are actively focusing on developing innovative devices and expanding their product portfolios through strategic partnerships, mergers, and acquisitions. Medtronic and Boston Scientific dominate the market due to their strong presence and wide range of offerings in spinal cord stimulators and other neuromodulation devices.


Moreover, emerging companies are entering the market, leveraging advanced technologies such as AI, machine learning, and data analytics to improve device precision and patient outcomes. The competitive environment is expected to intensify as these innovations continue to shape the industry.

Pain Management Devices Market Forecast  

The global pain management devices market size is projected to grow at a compound annual growth rate (CAGR) of 7.90% from 2024 to 2030. By 2030, the market is expected to reach USD 7.67 billion, driven by increasing demand for non-opioid pain therapies, advancements in medical technology, and the rising prevalence of chronic pain conditions. North America is expected to hold the largest market share, followed by Europe and the Asia-Pacific region.

Conclusion:

The pain management devices market offers promising growth opportunities, driven by the rising prevalence of chronic pain and the need for safer, more effective pain treatment options. With ongoing innovations and increasing investments in the sector, the market is poised for significant expansion by 2030.

Latest Reports Offered By DelveInsight:

Crows Feet Market 

DelveInsight's "Crows Feet Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Crows Feet, historical and forecasted epidemiology as well as the Crows Feet market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Dermatitis Seborrheic Market 

DelveInsight's "Seborrhoeic Dermatitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Seborrhoeic Dermatitis, historical and forecasted epidemiology as well as the Seborrhoeic Dermatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Gastro Intestinal Bleeding Market 

DelveInsight's "Gastro Intestinal Bleeding Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Gastro Intestinal Bleeding, historical and forecasted epidemiology as well as the Gastro Intestinal Bleeding market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.


Listeriosis Market 

DelveInsight’s comprehensive report titled “Listeriosis Market Insights, Epidemiology, and Market Forecast – 2034” offers a detailed analysis of Listeriosis. The report presents historical and projected epidemiological data covering incident cases of listeriosis, age-specific cases of listeriosis, gender-specific cases of listeriosis, risk-associated cases of listeriosis, and treated cases of listeriosis.


Point Of Care Glucose Testing Market 

DelveInsight’s ‘Point of Care Glucose Testing Market Insight, Competitive Landscape and Market Forecast, 2030’ report delivers an in-depth understanding of Point of Care Glucose Testing and the historical and forecasted Point of Care Glucose Testing market trends, globally, which comprises of North America, Europe, APAC, and RoW.


Substance Drug Abuse Market 

DelveInsight's "Substance (Drug) Abuse Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Substance (Drug) Abuse, historical and forecasted epidemiology as well as the Substance (Drug) Abuse market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Comments

Post a Comment

Popular posts from this blog

Raising the Bar: ADCs and Lung Cancer Treatment Breakthroughs

Image
  The ENHERTU Effect: A Closer Look at the Dynamic Duo Daiichi Sankyo and AstraZeneca Taking on HER2-mutant NSCLC Lung cancer remains one of the most challenging and prevalent forms of cancer. Within this landscape, innovative treatments are offering new hope. One such breakthrough is the collaboration between Daiichi Sankyo and AstraZeneca, which brings forth ENHERTU, an Antibody-Drug Conjugate (ADC). ENHERTU is making strides in targeting HER2-mutant Non-Small Cell Lung Cancer (NSCLC), a rare and challenging subset of the disease. The ENHERTU partnership aims to address this unmet medical need with a highly targeted approach. Dato-DXd vs. TRODELVY: The Battle of ADC Targeting TROP2 As the world of ADCs expands, another remarkable battle is brewing between Daiichi Sankyo's Dato-DXd and TRODELVY in their quest to target TROP2. TROP2, also known as CEACAM5, is an antigen overexpressed in various cancers, including endometrial cancer. Both ADCs hold the potential to transform the
Read more
Image
Covering the Therapeutic Advancements in Obstructive Sleep Apnea Treatment Scenario Obstructive Sleep Apnea (OSA) is a common chronic sleep disorder, which is characterized by periodic narrowing and obstruction of the pharyngeal airway during sleep, leading to a complete or partial obstruction of the airway, results of which are apneas, hypopneas, or sometimes both. Obstructive sleep apnea is a chronic and permanent condition, through proper therapy and medications the condition can be cured. Almost every system in the body is affected by Obstructive Sleep Apnea, resulting in an increased incidence of hypertension, stroke, altered immune system, and cardiovascular disease.  Obstructive Sleep Apnea is caused when the throat muscles relax during sleep, which causes the tissue in the back of the throat to collapse and block the upper airway. Daytime sleepiness is one of the most common symptoms of Obstructive Sleep Apnea. People affected with Obstructive Apnea also complain of memory pro
Read more

Market Drivers and Barriers for Vascular Stents: An In-Depth Analysis

Image
  What are Vascular Stents? Vascular stents are medical devices that are used to treat narrow or blocked blood vessels. They are small, mesh-like tubes that are inserted into the affected artery to help prop it open and improve blood flow. The global vascular stents market is expected to grow significantly in the coming years due to an increase in the prevalence of cardiovascular diseases, technological advancements in stent design, and the growing aging population. Vascular Stents Market Size and Forecast The global vascular stents market size is expected to reach USD 16.52 billion by 2028, growing at a CAGR of 6.7% from 2021 to 2028. North America dominates the market due to a high prevalence of cardiovascular diseases, increased healthcare spending, and better healthcare infrastructure. Vascular Stents Market Trends and Analysis The market is experiencing a shift towards the development of bioresorbable stents that dissolve within the body after the artery has healed. This reduces
Read more